NCT07482852 (VR-MOVE) is a NA clinical trial of VR social musical exergame in Depression, sponsored by Hunan University of Traditional Chinese Medicine.

Who is sponsoring NCT07482852?

NCT07482852 is sponsored by Hunan University of Traditional Chinese Medicine.

What drugs are being tested in NCT07482852?

Interventions in NCT07482852: VR social musical exergame, VR solo musical exergame, Waitlist control.

What condition does NCT07482852 study?

NCT07482852 studies Depression, Anxiety.

Is NCT07482852 still recruiting?

NCT07482852 is currently not yet recruiting. Last updated 19 March 2026.

Last reviewed 2026-03-19 · How we verify

NCT07482852: VR-MOVE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Controlled Trial of a VR Social Music-Movement Exergame for Depression and Anxiety in Young Adults

Not yet recruiting NA Last updated 19 March 2026

What this trial tests

NA trial testing VR social musical exergame in Depression in 130 participants. Not yet recruiting.

Timeline

1 April 2026

Primary endpoint
1 March 2028

1 May 2028

Quick facts

Lead sponsor	Hunan University of Traditional Chinese Medicine
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	130
Start date	1 April 2026
Primary completion	1 March 2028
Estimated completion	1 May 2028

Drugs / interventions tested

VR social musical exergame
VR solo musical exergame
Waitlist control

Conditions studied

Depression — all drugs for Depression →
Anxiety — all drugs for Anxiety →

Sponsor

Hunan University of Traditional Chinese Medicine

Who can join

Adults 18 to 25, any sex, with Depression or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the effectiveness of a virtual reality (VR) music-movement exergaming intervention for improving social connectedness and psychological well-being among young adults. Participants will be randomly assigned to one of three groups: (1) a VR social music-movement exergame group, (2) a VR solo exergame group without social interaction, and (3) a waitlist control group. The intervention integrates rhythmic movement, music-based interaction, and immersive VR environments to promote engagement and social connection. Primary outcomes include changes in depressive symptoms, anxiety, and social connectedness. Secondary outcomes include psychological need satisfaction and physical fitness indicators. Assessments will be conducted at baseline, post-intervention, and follow-up. The study will provide evidence on the potential benefits of immersive VR-based exergaming interventions for mental health and social well-being in young adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Virtual Reality-Based Social Musical Exergame Guided by Self-Determination Theory for Young Adults With Depression and Anxiety: Protocol for a Randomized Controlled Trial.
Wan G, Zhang Y, Li M. · · 2026 · PMID 42066290 · DOI 10.2196/83737

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting

Other Hunan University of Traditional Chinese Medicine trials

Trials by the same sponsor.

NCT06532864 — Qigong Exercise and Sleep Quality · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07482852 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hunan University of Traditional Chinese Medicine
Last refreshed: 19 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07482852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing